Scarica l'app Stockscreener
59.65
1.43%
0.84
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$58.81
Aprire:
$58.81
Volume 24 ore:
1.94M
Relative Volume:
0.99
Capitalizzazione di mercato:
$9.29B
Reddito:
$1.17B
Utile/perdita netta:
$150.71M
Rapporto P/E:
63.46
EPS:
0.94
Flusso di cassa netto:
$245.03M
1 W Prestazione:
+0.73%
1M Prestazione:
-5.24%
6M Prestazione:
+12.17%
1 anno Prestazione:
-16.55%
Intervallo 1D:
$58.40
$60.53
Intervallo di 1 settimana:
$58.40
$60.53
Portata 52W:
$46.01
$79.28
Bio Techne Corp Stock (TECH) Company Profile
Nome
Bio Techne Corp
Settore
Industria
Telefono
612-379-8854
Indirizzo
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Confronta TECH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
59.65 | 9.16B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-03 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2025-07-09 | Iniziato | TD Cowen | Buy |
| 2025-05-30 | Iniziato | Wells Fargo | Overweight |
| 2025-04-09 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | Iniziato | Evercore ISI | Outperform |
| 2025-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-02-08 | Iniziato | Scotiabank | Sector Outperform |
| 2024-02-02 | Downgrade | Stifel | Buy → Hold |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-08-28 | Iniziato | William Blair | Outperform |
| 2023-01-10 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Aggiornamento | Stifel | Hold → Buy |
| 2021-01-25 | Reiterato | The Benchmark Company | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-07-15 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Downgrade | Stifel | Buy → Hold |
| 2020-05-14 | Iniziato | The Benchmark Company | Buy |
| 2020-01-08 | Ripresa | Stephens | Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-02 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-14 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Downgrade | Craig Hallum | Buy → Hold |
| 2018-10-17 | Iniziato | Goldman | Neutral |
| 2018-06-15 | Iniziato | Argus | Buy |
| 2017-07-13 | Iniziato | Wells Fargo | Market Perform |
| 2017-02-09 | Iniziato | Citigroup | Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Buy |
| 2016-11-10 | Ripresa | Leerink Partners | Outperform |
| 2015-01-21 | Reiterato | Robert W. Baird | Outperform |
| 2013-09-20 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
Mostra tutto
Bio Techne Corp Borsa (TECH) Ultime notizie
Fort Washington Investment Advisors Inc. OH Buys 35,165 Shares of Bio-Techne Corp $TECH - MarketBeat
Research Tools & Consumables Stocks Q3 Results: Benchmarking Bio-Techne (NASDAQ:TECH) - Yahoo Finance
Bio-Techne Corp (TECH) Stock Price History & Data - Traders Union
Voya Investment Management LLC Has $7.04 Million Holdings in Bio-Techne Corp $TECH - MarketBeat
Assenagon Asset Management S.A. Invests $2.75 Million in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference - Investing News Network
Bio-Techne (TECH): Revisiting Valuation as Recent Gains Contrast a Weak One-Year Shareholder Return - Yahoo Finance
Bio-Techne Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Riverbridge Partners LLC Trims Stock Position in Bio-Techne Corp $TECH - MarketBeat
Will Bio Techne Corporation stock gain from strong economyMarket Rally & Free Low Drawdown Momentum Trade Ideas - Улправда
Why Bio Techne Corporation stock appeals to analystsJuly 2025 Momentum & Capital Protection Trade Alerts - Улправда
Will New 3D Multiomic Workflow and Leo System Expansion Change Bio-Techne's (TECH) Narrative? - simplywall.st
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
How Bio Techne Corporation stock compares to industry benchmarksJuly 2025 Rallies & Free Weekly Watchlist of Top Performers - DonanımHaber
Bio-Techne (NASDAQ:TECH) Downgraded to Strong Sell Rating by Zacks Research - MarketBeat
Trading Action: Will Bio Techne Corporation stock gain from strong economyMarket Volume Summary & Technical Pattern Based Buy Signals - Улправда
Thrivent Financial for Lutherans Has $11.53 Million Holdings in Bio-Techne Corp $TECH - MarketBeat
Corient Private Wealth LLC Reduces Stake in Bio-Techne Corp $TECH - MarketBeat
Aaron Wealth Advisors LLC Takes $980,000 Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Bio-Techne Stock: Is TECH Underperforming the Healthcare Sector? - Barchart.com
Neuberger Berman Group LLC Has $128.62 Million Stake in Bio-Techne Corp $TECH - MarketBeat
Reassessing Bio-Techne (TECH) Valuation After a Weak Year and Recent Share Price Rebound - simplywall.st
Bamco Inc. NY Has $143.81 Million Stake in Bio-Techne Corp $TECH - MarketBeat
4D Advisors LLC Makes New $2.06 Million Investment in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
GMP Cytokine Market and Competition Outlook to 2031: Growing at 8.4% CAGR, Led by Bio-Techne, PeproTech, CellGenix Among OthersResearchAndMarkets.com - The AI Journal
Osterweis Capital Management Inc. Has $7.70 Million Stake in Bio-Techne Corp $TECH - MarketBeat
Cerity Partners LLC Boosts Stake in Bio-Techne Corp $TECH - MarketBeat
Check out Bio-Techne Corp's stock price (1TECH-IT) in real time - CNBC
Here’s Why BioTechne (TECH) Traded Lower in Q3 - Yahoo Finance
Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology - Investing News Network
Bio-techne and Wyss Center partner to develop automated 3D multiomics - Investing.com
Bio-Techne (NASDAQ: TECH) and Wyss Geneva to develop automated 3D multiomics workflow - Stock Titan
Amundi Buys 19,844 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp $TECH Stake Lessened by SVB Wealth LLC - MarketBeat
Bio-Techne Corp (NASDAQ:TECH) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Does Bio-Techne’s Recent Weakness Offer an Opportunity After Its Cell and Gene Therapy Push? - Yahoo Finance
Bio-Techne Announces Expanded Launch Of Next-Generation Leo System - Nasdaq
Bio-Techne Launches the Enhanced Leo System Delivering Advanced Multiplexing and High-Throughput Protein Analysis - Investing News Network
Bio-techne ships enhanced Leo System with expanded detection capabilities - Investing.com
Bio-Techne (NASDAQ: TECH) debuts Leo system with dual-channel fluorescence - Stock Titan
Transcript : Bio-Techne Corporation Presents at 53rd Annual Nasdaq Investor Conference, Dec-09-2025 09 - marketscreener.com
Bio-Techne Corp. stock outperforms competitors despite losses on the day - MarketWatch
WINTON GROUP Ltd Makes New $6.23 Million Investment in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp $TECH Shares Sold by Invesco Ltd. - MarketBeat
Arrowstreet Capital Limited Partnership Has $18.94 Million Stake in Bio-Techne Corp $TECH - MarketBeat
Quantbot Technologies LP Purchases New Stake in Bio-Techne Corp $TECH - MarketBeat
Baird Financial Group Inc. Has $29.11 Million Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Cresset Asset Management LLC Boosts Holdings in Bio-Techne Corp $TECH - MarketBeat
Bio Techne Corp Azioni (TECH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Bio Techne Corp Azioni (TECH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Geist William | PRESIDENT, PROTEIN SCIENCES |
Nov 03 '25 |
Option Exercise |
0.00 |
9,911 |
0 |
25,023 |
| Nusse Roeland | Director |
Aug 25 '25 |
Option Exercise |
21.84 |
17,040 |
372,154 |
61,599 |
| Nusse Roeland | Director |
Aug 25 '25 |
Sale |
56.36 |
17,040 |
960,388 |
44,559 |
| BAUMGARTNER ROBERT V | Director |
Aug 25 '25 |
Option Exercise |
21.84 |
17,040 |
372,154 |
61,903 |
| BAUMGARTNER ROBERT V | Director |
Aug 25 '25 |
Sale |
56.21 |
17,040 |
957,818 |
44,863 |
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):